A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 59
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : KTP
Long Form : ketoprofen
No. Year Title Co-occurring Abbreviation
2022 Mechanistic insights into encapsulation and release of drugs in colloidal niosomal systems: biophysical aspects. DLS, DSC, HSA, ITC, MTX
2021 A New Crystalline Ketoprofen Sodium Salt: Solid-State Characterization, Solubility, and Stability. API, DSC, FTIR, TGA, XRD
2021 Ketoprofen Combined with UVA Irradiation Exerts Higher Selectivity in the Mode of Action against Melanotic Melanoma Cells than against Normal Human Melanocytes. UVA-R
2020 Comparison of three electromembrane-based extraction systems for NSAIDs analysis in human urine samples. DIC, EME, FM-EME, IBU, LOD, muF-EME, NAX, SAC
2020 FTIR combined with chemometric tools (fingerprinting spectroscopy) in comparison to HPLC: which strategy offers more opportunities as a green analytical chemistry technique for pharmaceutical analysis. BENZ, DEX, FTIR, GAC, HPLC, HYS, PLSR, RMSECV
2020 Partitioning of surfactant into drug-rich nanodroplets and its impact on drug thermodynamic activity and droplet size. ASD, CTAB, SDS
2020 Solubility and thermodynamic analysis of ketoprofen in organic solvents. ---
2019 Catalytic Ozonation of Ketoprofen with In Situ N-Doped Carbon: A Novel Synergetic Mechanism of Hydroxyl Radical Oxidation and an Intra-Electron-Transfer Nonradical Reaction. NHC
2019 On-chip electromembrane extraction of acidic drugs. DIC, IBU, NAX, NPOE, NSAIDs, PMMA, SAL, SLM
10  2019 Sorption of ionic and neutral species of pharmaceuticals to loessial soil amended with biochars. ATL, CBZ
11  2019 Transdermal enhancement strategy of ketoprofen and teriflunomide: The effect of enhanced drug-drug intermolecular interaction by permeation enhancer on drug release of compound transdermal patch. AZ, TEF
12  2018 Chronotherapeutic Drug Delivery of Ketoprofen and Ibuprofen for Improved Treatment of Early Morning Stiffness in Arthritis Using Hot-Melt Extrusion Technology. CTDDS, EC, ES100, HME, IBU
13  2018 Fabrication of calixarene-grafted bio-polymeric magnetic composites for magnetic solid phase extraction of non-steroidal anti-inflammatory drugs in water samples. FNP, IBP, INP, LODs, LOQ, MSPE, NSAIDs
14  2018 Franz Diffusion Cell Approach for Pre-Formulation Characterisation of Ketoprofen Semi-Solid Dosage Forms. ---
15  2018 New sporopollenin-based beta-cyclodextrin functionalized magnetic hybrid adsorbent for magnetic solid-phase extraction of nonsteroidal anti-inflammatory drugs from water samples. FNP, IBP, INP, MSPE, NSAIDs, TDI
16  2018 Pharmaceutical grey water footprint: Accounting, influence of wastewater treatment plants and implications of the reuse. CBZ, DCF, GWFP, NPX, WWTPs
17  2018 Roles of hydrophobic and hydrophilic fractions of dissolved organic matter in sorption of ketoprofen to biochars. DOM, HiN, HOA, SSA, Sw
18  2017 Preparation and characterization of beta-cyclodextrin grafted N-maleoyl chitosan nanoparticles for drug delivery. CD, DS
19  2016 An effective microfluidic based liquid-phase microextraction device (muLPME) for extraction of non-steroidal anti-inflammatory drugs from biological and environmental samples. DIC, IBU, LPME, muLPME, NAX, NSAIDs, SAC
20  2016 Exploratory human PET study of the effectiveness of (11)C-ketoprofen methyl ester, a potential biomarker of neuroinflammatory processes in Alzheimer's disease. AD, COX-1, MCI, PET, PiB
21  2016 Modeling the fate of a photoproduct of ketoprofen in urban rivers receiving wastewater treatment plant effluent. EBP, WWTPs
22  2016 Pharmacokinetics of ketoprofen enantiomers following intravenous and oral administration to exercised Thoroughbred horses. ---
23  2016 Variable Effects of Non-steroidal Anti-inflammatory Drugs (NSAIDs) on Selected Biochemical Processes Mediated by Soil Microorganisms. DCF, IBF, NPX, NSAIDs, SIR, URE
24  2015 Impact of sludge stabilization processes and sludge origin (urban or hospital) on the mobility of pharmaceutical compounds following sludge landspreading in laboratory soil-column experiments. ATN, CBZ, CIP, DIC, ECZ, IBU, PAR, SAL, SMX
25  2015 Influence of pressurized carbon dioxide on ketoprofen-incorporated hot-melt extruded low molecular weight hydroxypropylcellulose. HME, HPC, PG
26  2014 Co-metabolic oxidation of pharmaceutical compounds by a nitrifying bacterial enrichment. AMO, CBZ, DXM, IBP, IOP
27  2014 Human whole-body biodistribution and dosimetry of a new PET tracer, [(11)C]ketoprofen methyl ester, for imagings of neuroinflammation. NSAIDs
28  2014 Ion-exchange selectivity of diclofenac, ibuprofen, ketoprofen, and naproxen in ureolyzed human urine. AER, DCF, IBP, NPX, NSAIDs, PCM
29  2013 Chitosan-graft-beta-cyclodextrin nanoparticles as a carrier for controlled drug release. beta-CD, CS, DS
30  2013 Gamma scintigraphy in the analysis of ketoprofen behaviour from matrix tablets. GIT
31  2013 Removal of non-steroidal anti-inflammatory drugs ibuprofen and ketoprofen from water by emulsion liquid membrane. ELM, IBP
32  2012 Alteration of hemostasis in patients treated with subgingival NSAIDs during periodontal therapy. ASA
33  2012 In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures. AUC, DE, HPC, MDT, SEM, XRPD
34  2012 Interactions of acidic pharmaceuticals with human serum albumin: insights into the molecular toxicity of emerging pollutants. CA, DCF, HSA
35  2012 The influence of the polar head and the hydrophobic chain on the skin penetration enhancement effect of poly(ethylene glycol) derivatives. PEG
36  2011 Clinical pharmacokinetics of ketoprofen enantiomers in wild type of Cyp 2c8 and Cyp 2c9 patients with rheumatoid arthritis. RA
37  2011 Development and validation of a confirmatory method for the determination of 12 non steroidal anti-inflammatory drugs in milk using liquid chromatography-tandem mass spectrometry. CPF, DC, FLU, MF, MLX, NP, NSAIDs, OPB, PBZ, TLF, VDP
38  2011 Electromembrane extraction (EME) and HPLC determination of non-steroidal anti-inflammatory drugs (NSAIDs) in wastewater samples. DAD, DIC, EME, FLD, IBU, KTR, NAX, NSAIDs, SAC, SLM
39  2009 The use of topical subgingival gels of non-steroidal anti-inflammatory drugs (NSAIDs) as an adjunct to non-surgical management of chronic periodontitis. ASA, NSAIDs
40  2007 Pharmacokinetics of ketoprofen in the green iguana (Iguana iguana) following single intravenous and intramuscular injections. i.v, IM
41  2004 A pharmacokinetic comparison of meloxicam and ketoprofen following oral administration to healthy dogs. AUC, HPLC, MLX
42  2004 The influence of guaifenesin and ketoprofen on the properties of hot-melt extruded polyethylene oxide films. ASTM, DSC, GFN, PEO, SEM, XRD
43  2003 Ketoprofen in the cat: pharmacodynamics and chiral pharmacokinetics. COX, TX
44  2003 Pharmacodynamics, chiral pharmacokinetics and PK-PD modelling of ketoprofen in the goat. COX, MRT, NSAIDs, PGE2, TXB2
45  2002 Determination of ketoprofen enantiomers in human serum by capillary zone electrophoresis: man pharmacokinetic studies after administration of rac-ketoprofen tablets. BGE, CV, CZE, IS, TMbetaCD
46  2001 Antibodies directed to drug epitopes to investigate the structure of drug-protein photoadducts. Recognition of a common photobound substructure in tiaprofenic acid/ketoprofen cross-photoreactivity. SUP, TPA
47  2001 Enantiospecific pharmacokinetics of ketoprofen in plasma and synovial fluid of horses with acute synovitis. NSAID
48  2001 Pharmacodynamics and pharmacokinetics of ketoprofen enantiomers in sheep. COX, PGE2, TXB2
49  2000 Enantiospecific pharmacokinetics and pharmacodynamics of ketoprofen in sheep. APA, Emax, i.v, NSAID, PK/PD
50  2000 Pharmacodynamic effects of ketoprofen on crevicular fluid prostanoids in adult periodontitis. GCF, LTB4, NSAIDs, PGE2
51  1999 Bioavailability of racemic ketoprofen in healthy horses following rectal administration. NSAID
52  1999 In vivo and in vitro toxicodynamic analyses of new quinolone-and nonsteroidal anti-inflammatory drug-induced effects on the central nervous system. ENX, FLB, FRP, GABA, NQs, NSAIDs
53  1998 Pharmacokinetic and safety evaluations of ketoprofen gels in subjects with adult periodontitis. Tmax
54  1996 Pharmacokinetics and pharmacodynamics of ketoprofen enantiomers in the horse. COX, NSAID, PK/PD
55  1995 Comparison of the anti-inflammatory actions of flunixin and ketoprofen in horses applying PK/PD modelling. FXN, LT, NSAIDs, PD, PG, PK, TX
56  1995 Influence of formulation on the pharmacokinetics and bioavailability of racemic ketoprofen in horses. rac
57  1995 Pharmacokinetics and pharmacodynamics of ketoprofen in calves applying PK/PD modelling. BK, PD, PK, Vd
58  1985 Neurotensin-induced colonic motor responses in dogs: a mediation by prostaglandins. ASA, NT
59  1984 [Interaction of suprofen and serum albumin]. BSA, HSA, IM, SPF